which is consistent with some newer high-quality studies, and I think is an important thing when you're conjecturing on how aneurysms should be managed.

I agree with all of you, obviously.

If I may start, I would say that the team behind these trials, the UK colleagues and the colleagues surrounding Frank Leather and the Veteran Affairs Association, They are amazing and they have led the search for evidence in our field.

And basically the only teams that bring up level A evidence for us.

Because the same teams basically have also continued with the EVAR trial and the screening trials.

So they have really contributed a lot, I think.

And also amazingly, they are in many ways outdated, but they are still super relevant.

And are you using inner-to-inner or outer-to-outer measurements on those?